US · Healthcare

Biomotion Sciences Ordinary Shares (SLXN)

Biotechnology

Biomotion Sciences Ordinary Shares (SLXN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SLXN

P/E ratio

18.00

Biomotion Sciences Ordinary Shares (SLXN) — FAQ

What is SLXN's P/E ratio?

The price-to-earnings (P/E) ratio for Biomotion Sciences Ordinary Shares (SLXN) is 18.00 (data as of 2026-03-25).

Does Biomotion Sciences Ordinary Shares pay a dividend?

Dividend yield is not available in the current snapshot for Biomotion Sciences Ordinary Shares (SLXN). Check the MyAverix Finance app for the latest dividend data.

What sector is Biomotion Sciences Ordinary Shares in?

Biomotion Sciences Ordinary Shares (SLXN) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SLXN listed on?

SLXN is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)